tatCN21

N/A

Report date: 2025/03/20 09:14:51

Base Information

Drug NametatCN21
Drug Alias NameCaMKIIN derived peptide (University of Colorado)neuroprotective peptide (University of Colorado)CaMKII inhibitor (University of Colorado)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCalcium/Calmodulin dependent protein kinase II inhibitors
TargetsCalcium/Calmodulin dependent protein kinase II
Therapy Area/IndicationsTrauma, Nervous SystemStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado System
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Colorado SystemUniversity Of Colorado
Inactive CompaniesN/A
Active IndicationsTrauma, Nervous SystemStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A